AIA Group’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.37M Buy
15,947
+1,823
+13% +$393K 0.05% 190
2025
Q4
$2.9M Buy
+14,124
New +$2.66M 0.04% 198
2023
Q2
Sell
-3,216
Closed -$243K 344
2023
Q1
$243K Sell
3,216
-384
-11% -$29K 0.01% 304
2022
Q4
$277K Buy
3,600
+1,476
+69% +$112K 0.02% 294
2022
Q3
$142K Sell
2,124
-759
-26% -$48.1K 0.01% 337
2022
Q2
$151K Hold
2,883
0.01% 406
2022
Q1
$163K Buy
2,883
+836
+41% +$44.8K 0.01% 408
2021
Q4
$105K Buy
+2,047
New +$100K 0.01% 409

Other funds holding CAH

AIA Group's CAH Position: Q1 2026 in Review

AIA Group increased its Cardinal Health (CAH) stake by 13% in Q1 2026, buying an estimated $393K and bringing the position to 15,947 shares worth $3.37M. The position accounts for 0.05% of the portfolio, ranked #190.

AIA Group first reported a position in CAH in Q4 2021 and has held it in 8 quarters since. 1,423 funds tracked by Wall St. Rank hold CAH as of Q1 2026.

  • AIA Group held 15,947 shares of Cardinal Health worth $3.37M as of Q1 2026.
  • AIA Group bought 1,823 Cardinal Health shares in Q1 2026, an estimated $393K.
  • Cardinal Health made up 0.05% of AIA Group's portfolio in Q1 2026, its #190 holding.
  • AIA Group first reported a position in Cardinal Health in Q4 2021 and has held it in 8 quarters since.
  • 1,423 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.

Based on AIA Group's 13F filing for Q1 2026, filed 6 May 2026.